S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:RARE

Ultragenyx Pharmaceutical SEC Filings & 10K Form

$118.50
-0.13 (-0.11 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$110.66
Now: $118.50
$120.84
50-Day Range
$118.63
MA: $144.89
$167.73
52-Week Range
$31.99
Now: $118.50
$179.65
Volume525,045 shs
Average Volume467,422 shs
Market Capitalization$7.93 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.19

SEC Filings

Ultragenyx Pharmaceutical (NASDAQ:RARE) SEC Filings

DateFilerForm TypeView
03/03/2021
7:55 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:48 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:47 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:43 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:42 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:39 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:38 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:37 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:36 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
1:30 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
12:24 PM
Capital World Investors (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
02/16/2021
12:16 PM
Capital Research Global Investors (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
02/12/2021
12:06 PM
FEDERATED HERMES, INC. (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
02/03/2021
7:04 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
7:03 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
7:02 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
7:01 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/02/2021
3:28 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
7:30 AM
BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
01/21/2021
7:46 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:01 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:15 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
6:05 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
8:16 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
5:45 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:15 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
3:55 PM
Arcturus Therapeutics Holdings Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
3:51 PM
Arcturus Therapeutics Holdings Inc. (Subject)
Ultragenyx Pharmaceutical (Filed by)
Form SC 13D/A
12/07/2020
5:04 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
3:16 PM
Solid Biosciences Inc. (Subject)
Ultragenyx Pharmaceutical (Filed by)
Form SC 13D
11/04/2020
2:44 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
4:05 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
3:05 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
4:28 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2020
4:26 PM
Solid Biosciences Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2020
3:02 PM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
10/28/2020
6:52 AM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
10/27/2020
3:20 PM
Ultragenyx Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2020
3:07 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:11 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2020
7:16 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
6:23 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:22 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:21 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:20 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:20 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:19 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:18 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:16 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:15 PM
Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
4:55 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
4:53 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
4:52 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
4:52 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/13/2020
5:07 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2020
1:57 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
3:47 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:26 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
8:00 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
2:56 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
1:12 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
1:11 PM
Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
11:21 AM
SIEGALL CLAY B (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2020
10:29 AM
Ultragenyx Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2020
12:22 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
4:21 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
11:30 AM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
11:29 AM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
1:21 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
1:21 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
2:03 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
12:16 PM
Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:15 PM
SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:14 PM
SIEGALL CLAY B (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:13 PM
NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:12 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:11 PM
Ekman Lars (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:10 PM
Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
12:10 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
12:47 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
12:46 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
1:00 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
3:59 PM
Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
1:21 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
1:20 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
1:19 PM
Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
1:18 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
1:17 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
2:14 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:21 PM
Arcturus Therapeutics Holdings Inc. (Subject)
Ultragenyx Pharmaceutical (Filed by)
Form SC 13D/A
05/22/2020
12:41 PM
Arcturus Therapeutics Holdings Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
6:50 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
6:49 PM
Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:15 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:13 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:12 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:25 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:31 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
12:21 PM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
05/08/2020
7:12 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.